成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 844499-71-4 Chemical Structure| 844499-71-4
Chemical Structure| 844499-71-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 844499-71-4

,{[proInfo.pro_purity]}

A-769662 is an AMP-activated protein kinase (AMPK) agonist with high affinity for AMPK, with an EC50 value of 0.8 μM. A-769662 has antidiabetic and antiobesity effects and can be used in research on metabolic diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of A-769662

CAS No. :844499-71-4
Formula : C20H12N2O3S
M.W : 360.39
SMILES Code : N#CC1=C(O)C(C(C2=CC=C(C3=CC=CC=C3O)C=C2)=CS4)=C4NC1=O
MDL No. :MFCD11977269
InChI Key :CTESJDQKVOEUOY-UHFFFAOYSA-N
Pubchem ID :54708532

Safety of A-769662

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of A-769662

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
chondrocytes 5 μM 12 h To explore the effect of the AMPK activator A-769662 on autophagy in chondrocytes, the results showed that A-769662 significantly increased autophagy levels and alleviated pyroptosis induced by P2X7 overactivation. PMC8580998
C2C12 myotubes 100 μM 48 h A-769662 prevented IFN c/TNF a-induced myotube atrophy and restored normal metabolic function and anabolic signaling. PMC6034131
L6 myotubes 100 μM 16 h To assess the effect of AMPK activation on PLIN3 expression, results showed that A-769662 significantly increased PLIN3 gene expression. PMC5021677
Bone marrow-derived macrophages (BMDMs) 20 μM 24 h A-769662 enhances AMPK activation, thereby reducing the expression of iNOS, IL-1β, IL-6, and TNF-α PMC8005550
ME/CFS lymphoblasts 30 μM 4 h To measure AMPK activity, results showed a slight increase in AMPK activity in ME/CFS lymphoblasts, but it did not reach statistical significance. PMC7921983
Mouse primary hepatocytes 30 μM 3 h To investigate the effect of A-769662 on lipid synthesis, results showed that A-769662 significantly decreased intracellular TG accumulation. PMC5835560

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
mice LPS-induced septic cachexia model intraperitoneal injection 500 mg/kg single injection, lasting 18 hours A-769662 completely prevented LPS-induced muscle atrophy and reduced the expression of Atrogin-1/MAFbx and MuRF1. PMC6034131
Balb/c mice LPS-induced lethal inflammation model Intraperitoneal injection 30 mg/kg Single dose, observed for 7 days To evaluate the potential roles of A-769662 in LPS-induced inflammatory injury, the results showed that A-769662 suppressed LPS-induced elevation of IL-6, alleviated histological abnormalities in lung, and improved the survival of LPS-challenged mice. PMC6026648
Mice Diet-induced obese (DIO) mouse model Intraperitoneal injection 30 mg/kg Twice daily for 5 days To investigate the effect of A-769662 on liver lipid content in obese mice, results showed that A-769662 significantly reduced liver triglyceride content. PMC5835560
mice acute model of atherogenesis induced by PCSK9-AAV intraperitoneal injection 30 mg/kg daily for 6 weeks To evaluate the effect of A-769662 as an intervening therapy on atherosclerosis, results showed no significant treatment effect, with no differences observed in plaque size, lipid content, or necrotic area. PMC7707174
Mice LPS/D-Gal-induced fulminant liver injury model Intraperitoneal injection 30 mg/kg Single dose, 6 hours duration To investigate the involvement of AMPK in the hepatoprotective effects of 4-OI, results showed that A-769662 reversed the suppressive effects of 4-OI on AMPK/JNK phosphorylation and abolished the alleviated hepatic apoptosis by 4-OI PMC10390640

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.87mL

2.77mL

1.39mL

27.75mL

5.55mL

2.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories